pscAAV-CAG-RLuc Citations (2)
Originally described in: Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle.Paulk NK, Pekrun K, Charville GW, Maguire-Nguyen K, Wosczyna MN, Xu J, Zhang Y, Lisowski L, Yoo B, Vilches-Moure JG, Lee GK, Shrager JB, Rando TA, Kay MA Mol Ther Methods Clin Dev. 2018 Jul 24;10:144-155. doi: 10.1016/j.omtm.2018.06.001. eCollection 2018 Sep 21. PubMed Journal
Articles Citing pscAAV-CAG-RLuc
| Articles |
|---|
The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner.
Gonzalez-Sandoval A, Pekrun K, Tsuji S, Zhang F, Hung KL, Chang HY, Kay MA.
Nat Commun. 2023 Apr 28;14(1):2448. doi: 10.1038/s41467-023-38106-3.
PubMed
Associated Plasmids |
| Human Pluripotent Stem Cell-Derived Retinal Organoids: A Viable Platform for Investigating the Efficacy of Adeno-Associated Virus Gene Therapy. Na HJ, Kwon JE, Kim SH, Ahn J, Kwon OS, Chung KS. Int J Stem Cells. 2024 May 30;17(2):204-211. doi: 10.15283/ijsc23071. Epub 2024 Jan 22. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.